Results for
""Quinazolines""[mesh_terms]

2-Substituted-mercapto-quinazolin-4(3H)-ones as DHFR Inhibitors.

Mohamed A Sabry, Hussein I El-Subbagh

Mini reviews in medicinal chemistry 2021;21(16):2249-2260

Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib insensitive breast cancer models.

Walter Kolch, Robert O'Connor, John Crown, Norma O'Donovan, Neil Conlon, Sandra Roche, Tapesh Santra

PloS one 2017;12(5):e0177058

Multidirectional desymmetrization of pluripotent building block en route to diastereoselective synthesis of complex nature-inspired scaffolds.

Taleb H Al-Tel, Matthew John O'Connor, Raed A AlQawasmeh, Anusha Sebastian, Hany Omar, Scott McN Sieburth, Monther A Khanfar, Saleh Ibrahim, Paul Schilf, Vunnam Srinivasulu

Nature communications 2018;9(1):4989

The Mystery of EVP4593: Perspectives of the Quinazoline-Derived Compound in the Treatment of Huntington's Disease and Other Human Pathologies.

Vladimir A Vigont, Elena V Kaznacheyeva, Anna A Kruchinina, Dmitriy A Grekhnev

International journal of molecular sciences 2022;23(24):

Computational Fragment-Based Design of Phytochemical Derivatives as EGFR Inhibitors.

Fayaz Shaik Mohammad, Gayathri Shama Bhat

Chemistry & biodiversity 2023;20(8):e202300681

Bevacizumab Combined with S-1 and Raltitrexed for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies: A Phase II Study.

Meng Qiu, Hong-Feng Gou, Ji-Yan Liu, Feng Bi, Yu Yang, Dan Cao, Ya-Li Shen, Xin Wang, Qiu Li, De-Yun Luo, Zhi-Ping Li, Ke Cheng, Yu-Wen Zhou, Ye Chen

The oncologist 2021;26(8):e1320-e1326

Unlocking the Potential of Alpelisib in Breast Cancer: A Comprehensive Review.

Vrushali P Patole, Manoj R Kumbhare, Siddhi M Chandak

Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 2025;41():e20250005

Selective sample treatment using molecularly imprinted polymers.

Valérie Pichon

Journal of chromatography. A 2007;1152(1-2):41-53

Raltitrexed for advanced colorectal cancer. The story so far.

S C Taylor

Cancer practice 2000;8(1):51-4

Model-informed approach to support pediatric dosing for the pan-PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors.

Rolf Burghaus, Jan Schlender, Peter N Morcos, Jonathan Moss, Dirk Garmann, John Chung, Joel M Reid, Margaret E Macy, Barrett H Childs, Adam Lloyd

Clinical and translational science 2023;16(7):1197-1209

Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia.

Herbert Marini, Antonio Micali, Francesco Squadrito, Domenica Altavilla, Elena B Adamo, Antonina Pisani, Andrea Valenti, Domenico Puzzolo, Cesare Lorenzini, Giovanni Crea, Natasha Irrera, Mariagrazia Rinaldi, Letteria Minutoli

International journal of molecular sciences 2017;17(8):1311

Mechanistic Study of Potent Fluorinated EGFR Kinase Inhibitors with a Quinazoline Scaffold against L858R/T790M/C797S Resistance Mutation: Unveiling the Fluorine Substituent Cooperativity Effect on the Inhibitory Activity.

Michelle M Kuttel, Neil Ravenscroft, Abdolkarim Farrokhzadeh, Farideh Badichi Akher

The journal of physical chemistry. B 2021;124(28):5813-5824

Phenylhydrazone and Quinazoline Derivatives from the Cold-Seep-Derived Fungus .

Nai-Yun Ji, Xiao-Nian Li, Bin-Gui Wang, Zhen-Zhen Shi, Sheng-Tao Fang, Ya-Ping Liu

Marine drugs 2021;19(1):

Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer.

Ann W Gramza, Tito Fojo, Sanjeeve Balasubramaniam, Ravi A Madan, Jean Ward, Maureen Edgerly, Jaydira Del Rivero

The oncologist 2020;24(1):16-e14